Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Preparation and in Vitro Evaluation of Novel Lipopeptide Transfection Agents for Efficient Gene Delivery

Identifieur interne : 001941 ( Main/Exploration ); précédent : 001940; suivant : 001942

Preparation and in Vitro Evaluation of Novel Lipopeptide Transfection Agents for Efficient Gene Delivery

Auteurs : TARWADI [Australie] ; Jalal A. Jazayeri [Australie] ; Richard J. Prankerd [Australie] ; Colin W. Pouton [Australie]

Source :

RBID : ISTEX:65BC9B2C89D7906CD0737131F787D5436D109E36

Abstract

Gene therapy by delivery of nonviral expression vectors is highly desirable, due to their safety, stability, and suitability for production as bulk pharmaceuticals. However, low transfection efficiency remains a limiting factor in application on nonviral gene delivery. Despite recent advances in the field, there are still major obstacles to overcome. In an attempt to construct more efficient nonviral gene delivery vectors, we have designed a series of novel lipopeptide transfection agents, consisting of an alkyl chain, one cysteine, 1 to 4 histidine and 1 to 3 lysine residues. The lipopeptides were designed to facilitate dimerization (by way of the cysteine residues), DNA binding at neutral pH (making use of charged lysine residues), and endosomal escape (by way of weakly basic histidine residues). DNA/lipopeptide complexes were evaluated for their biophysical properties and transfection efficiencies. The number and identity of amino acids incorporated in the lipopeptide construct affected their DNA/lipopeptide complex forming capacity. As the number of lysine residues in the lipopeptide increased, the DNA complexes formed became more stable, had higher zeta potential (particle surface charge), and produced smaller mean particle sizes (typically 110 nm at a charge ratio of 5.0 and 240 nm at a charge ratio of 1.0). The effect of inclusion of histidines in the lipopeptide moiety had the opposite effect on complex formation to lysine, but was necessary for high transfection efficiency. In vitro transfection studies in COS-7 cells revealed that the efficiency of gene delivery of the luciferase encoding plasmid, pCMV-Luc, mediated by all the lipopeptides, was much higher than poly(l-lysine) (PLL), which has no endosomal escape system, and in two cases was slightly higher than that of branched polyethylenimine (PEI). Lipopeptides with at least two lysine residues and at least one histidine residue produced spontaneous transfection complexes with plasmid DNA, indicating that endosomal escape was achieved by incorporation of histidine residues. These low molecular weight peptides can be readily synthesized and purified and offer new insights into the mechanism of action of transfection complexes.

Url:
DOI: 10.1021/bc700463q


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Preparation and in Vitro Evaluation of Novel Lipopeptide Transfection Agents for Efficient Gene Delivery</title>
<author>
<name sortKey="Tarwadi" sort="Tarwadi" uniqKey="Tarwadi" first="" last="Tarwadi">TARWADI</name>
</author>
<author>
<name sortKey="Jazayeri, Jalal A" sort="Jazayeri, Jalal A" uniqKey="Jazayeri J" first="Jalal A." last="Jazayeri">Jalal A. Jazayeri</name>
</author>
<author>
<name sortKey="Prankerd, Richard J" sort="Prankerd, Richard J" uniqKey="Prankerd R" first="Richard J." last="Prankerd">Richard J. Prankerd</name>
</author>
<author>
<name sortKey="Pouton, Colin W" sort="Pouton, Colin W" uniqKey="Pouton C" first="Colin W." last="Pouton">Colin W. Pouton</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:65BC9B2C89D7906CD0737131F787D5436D109E36</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1021/bc700463q</idno>
<idno type="url">https://api.istex.fr/ark:/67375/TPS-D2695JB1-8/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002C51</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002C51</idno>
<idno type="wicri:Area/Istex/Curation">002C51</idno>
<idno type="wicri:Area/Istex/Checkpoint">000846</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000846</idno>
<idno type="wicri:doubleKey">1043-1802:2008:Tarwadi:preparation:and:in</idno>
<idno type="wicri:Area/Main/Merge">001949</idno>
<idno type="wicri:Area/Main/Curation">001941</idno>
<idno type="wicri:Area/Main/Exploration">001941</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Preparation and in Vitro Evaluation of Novel Lipopeptide Transfection Agents for Efficient Gene Delivery</title>
<author>
<name sortKey="Tarwadi" sort="Tarwadi" uniqKey="Tarwadi" first="" last="Tarwadi">TARWADI</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Pharmaceutical Biology and Department of Pharmaceutics, Victorian College of Pharmacy, Monash University, 381 Royal Parade, Parkville, Victoria 3052</wicri:regionArea>
<wicri:noRegion>Victoria 3052</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Jazayeri, Jalal A" sort="Jazayeri, Jalal A" uniqKey="Jazayeri J" first="Jalal A." last="Jazayeri">Jalal A. Jazayeri</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Pharmaceutical Biology and Department of Pharmaceutics, Victorian College of Pharmacy, Monash University, 381 Royal Parade, Parkville, Victoria 3052</wicri:regionArea>
<wicri:noRegion>Victoria 3052</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Prankerd, Richard J" sort="Prankerd, Richard J" uniqKey="Prankerd R" first="Richard J." last="Prankerd">Richard J. Prankerd</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Pharmaceutical Biology and Department of Pharmaceutics, Victorian College of Pharmacy, Monash University, 381 Royal Parade, Parkville, Victoria 3052</wicri:regionArea>
<wicri:noRegion>Victoria 3052</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author>
<name sortKey="Pouton, Colin W" sort="Pouton, Colin W" uniqKey="Pouton C" first="Colin W." last="Pouton">Colin W. Pouton</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Pharmaceutical Biology and Department of Pharmaceutics, Victorian College of Pharmacy, Monash University, 381 Royal Parade, Parkville, Victoria 3052</wicri:regionArea>
<wicri:noRegion>Victoria 3052</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Australie</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Bioconjugate Chemistry</title>
<title level="j" type="abbrev">Bioconjugate Chem.</title>
<idno type="ISSN">1043-1802</idno>
<idno type="eISSN">1520-4812</idno>
<imprint>
<publisher>American Chemical Society</publisher>
<date type="e-published" when="2008-03-12">2008</date>
<date when="2008-04-16">2008</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="940">940</biblScope>
<biblScope unit="page" to="950">950</biblScope>
</imprint>
<idno type="ISSN">1043-1802</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1043-1802</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Gene therapy by delivery of nonviral expression vectors is highly desirable, due to their safety, stability, and suitability for production as bulk pharmaceuticals. However, low transfection efficiency remains a limiting factor in application on nonviral gene delivery. Despite recent advances in the field, there are still major obstacles to overcome. In an attempt to construct more efficient nonviral gene delivery vectors, we have designed a series of novel lipopeptide transfection agents, consisting of an alkyl chain, one cysteine, 1 to 4 histidine and 1 to 3 lysine residues. The lipopeptides were designed to facilitate dimerization (by way of the cysteine residues), DNA binding at neutral pH (making use of charged lysine residues), and endosomal escape (by way of weakly basic histidine residues). DNA/lipopeptide complexes were evaluated for their biophysical properties and transfection efficiencies. The number and identity of amino acids incorporated in the lipopeptide construct affected their DNA/lipopeptide complex forming capacity. As the number of lysine residues in the lipopeptide increased, the DNA complexes formed became more stable, had higher zeta potential (particle surface charge), and produced smaller mean particle sizes (typically 110 nm at a charge ratio of 5.0 and 240 nm at a charge ratio of 1.0). The effect of inclusion of histidines in the lipopeptide moiety had the opposite effect on complex formation to lysine, but was necessary for high transfection efficiency. In vitro transfection studies in COS-7 cells revealed that the efficiency of gene delivery of the luciferase encoding plasmid, pCMV-Luc, mediated by all the lipopeptides, was much higher than poly(l-lysine) (PLL), which has no endosomal escape system, and in two cases was slightly higher than that of branched polyethylenimine (PEI). Lipopeptides with at least two lysine residues and at least one histidine residue produced spontaneous transfection complexes with plasmid DNA, indicating that endosomal escape was achieved by incorporation of histidine residues. These low molecular weight peptides can be readily synthesized and purified and offer new insights into the mechanism of action of transfection complexes.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Tarwadi" sort="Tarwadi" uniqKey="Tarwadi" first="" last="Tarwadi">TARWADI</name>
</noRegion>
<name sortKey="Jazayeri, Jalal A" sort="Jazayeri, Jalal A" uniqKey="Jazayeri J" first="Jalal A." last="Jazayeri">Jalal A. Jazayeri</name>
<name sortKey="Pouton, Colin W" sort="Pouton, Colin W" uniqKey="Pouton C" first="Colin W." last="Pouton">Colin W. Pouton</name>
<name sortKey="Pouton, Colin W" sort="Pouton, Colin W" uniqKey="Pouton C" first="Colin W." last="Pouton">Colin W. Pouton</name>
<name sortKey="Prankerd, Richard J" sort="Prankerd, Richard J" uniqKey="Prankerd R" first="Richard J." last="Prankerd">Richard J. Prankerd</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001941 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001941 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:65BC9B2C89D7906CD0737131F787D5436D109E36
   |texte=   Preparation and in Vitro Evaluation of Novel Lipopeptide Transfection Agents for Efficient Gene Delivery
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021